Winston-Salem, NC – October 16, 2024 – Rives Consult is pleased to announce the addition of Jane Shen, Pharm.D., to our team as Executive Vice President of Clinical Affairs. Dr. Shen brings over two decades of experience in healthcare innovation, clinical trials, and strategic leadership, making her a valuable asset to our mission of assisting novel early stage med tech companies successfully launch in the US.
Dr. Shen is the Founder and President of ALTs Consulting, where she has spent nearly four years advising on healthcare innovation, healthtech, and digital health commercialization. Her expertise in research and development strategy, as well as clinical operations, has been instrumental in advancing innovative healthcare solutions.
Dr. Shen has held leadership roles at BIORG, INC., where she served as President and Board Member, guiding the company in pioneering organoid technology to accelerate drug discovery and development. Additionally, she was the Chief Strategy Officer at the Wake Forest Institute for Regenerative Medicine, where she led efforts in strategic development within regenerative medicine and personalized care.
Dr. Shen's extensive background also includes her tenure as the Head of Innovation Sector Development at the Wake Forest Innovation Quarter and President of Board of Directors at Wake Forest Healthcare Ventures, where she played a pivotal role in fostering innovation within the healthcare ecosystem. Her commitment to community and entrepreneurship is evident in her board memberships with Venture Café and Piedmont Renewal Network, where she championed educational equity and supported the growth of innovation communities.
Her earlier career includes strategy and clinical development roles at PMG Research, TransTech Pharma, and Novartis, where she led clinical programs across various therapeutic sectors.
Dr. Shen holds a Doctor of Pharmacy (PharmD) from the University of Southern California and completed her Postdoctoral Clinical Research Fellowship at Rutgers University.
“We are thrilled to have Dr. Jane Shen join our team,” said Rives Bird, President of Rives Consult. “Her vast experience and deep understanding of clinical trials along with healthcare innovation will be invaluable as we continue to help drive innovation and success with early medical device companies.”
For more information, please contact:
Rives Bird
President
Rives Consult